Robert H. Schneider, MD, FACC
November 24th, 2012
Author of Trial on Transcendental Meditation and Heart Disease Responds
Robert H. Schneider, MD, FACC
Dr. Robert H. Schneider, lead author of a recent study on cardiovascular benefits of Transcendental Meditation, responds to Larry Husten’s corrected critique of that study.
February 25th, 2010
Proposed Performance Measures for Hypertension and Stable Coronary Artery Disease Now Available for Public Comment!
Frederick Masoudi, MD, MSPH
The American College of Cardiology and the American Heart Association, collaborating with the American Medical Association’s Physician Consortium for Performance Improvement (PCPI), have drafted an updated set of clinical performance measures for assessing and improving the quality of ambulatory care of patients with hypertension and stable coronary artery disease. These measures, which assess processes of care (e.g., medication prescription) […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?